FDA advisory panel on the safety and efficacy of drug-eluting stents: summary of findings and recommendations.
Popma
Jeffrey J
JJ
Tufts Medical School, Boston, MA 21140, USA. Jeffrey.Popma@caritaschristi.org
Weiner
Bonnie
B
Cowley
Michael J
MJ
Simonton
Charles
C
McCormick
Dan
D
Feldman
Ted
T
D000818:Animals; D054855:Drug-Eluting Stents / Q000009:adverse effects; D004730:Endothelium, Vascular / Q000503:physiopathology; D006801:Humans; D015999:Multivariate Analysis; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011474:Prosthesis Design; D016032:Randomized Controlled Trials as Topic; D012042:Registries; D013927:Thrombosis / Q000503:physiopathology; D014481:United States; D014486:United States Food and Drug Administration
D010975:Platelet Aggregation Inhibitors